KAT6A and acute myeloid leukemia: Interestingly, while KAT6A’s catalytic activity supports acetylation of marks like H3K9ac, H3K23ac, and H3K23 propionylation [44, 45], deletion of the MYST domain, but not its catalytic activity, abolishes colony formation and leukemogenesis in mouse AML models (21).